Loading clinical trials...
Loading clinical trials...
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
The purposes of the study is to assess the ability of the 6-Minute Walking Test (6MWT) as a reliable and standardized objective outcome assessment and its relation to already established subjective patient reported outcome measures in patients suffering from lumbar degenerative disc disease. We want to use an existing smartphone-application that uses global positioning system (GPS) coordinates to measure walking distance. Applying self- measurement of the 6MWT before and after a therapeutic intervention, we determine objective functional impairment (OFI) in patients. The results of this study add to the understanding of achievable objective outcomes after therapeutic interventions applied to patients with DDD and examines patients acceptance for smartphone based self-measurement. Primary Objectives The primary objective is to determine the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD) Secondary objectives are 1. to correlate objective functional impairment (OFI) with already established patient-rated outcome measures (PROMs) in the sense of cross-validation. 2. To correlate OFI, as determined by the 6MWT with OFI that is determined by another objective test, the TUG test 3. to then analyze the change in OFI in patients before and after surgical intervention 4. to determine whether patients prefer the objective (6MWT) or subjective (PROMs) repeated assessment of their functional condition.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Kantonsspital St. Gallen / Department of Neurosurgery
Sankt Gallen, Canton of St. Gallen, Switzerland
Start Date
May 1, 2019
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
July 26, 2022
50
ACTUAL participants
Lead Sponsor
Cantonal Hospital of St. Gallen
Collaborators
NCT04641039
NCT04992572
NCT05029726
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions